Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DXS InternationalAQSE:DXSP Debt-to-Equity is 1.30 as of Apr. 2025, which is 348% above its 10-year median of 0.29. The stock has 5 warning signs investors should review. Among 562 Healthcare Providers & Services companies, DXS International ranks worse than 79.72% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for DXS International's Debt-to-Equity or its related term are showing as below:
AQSE:DXSP'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13 Med: 0.29 Max: 1.55
Current: 1.3
During the past 11 years, the highest Debt-to-Equity Ratio of DXS International was 1.55. The lowest was 0.13. And the median was 0.29.
AQSE:DXSP's Debt-to-Equity is ranked worse than 79.72% of 562
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs AQSE:DXSP: 1.30
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
DXS International Debt-to-Equity Related Terms
DXS International Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for DXS International's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AQSE:DXSP vs VEEV, BTSG, HQY: Debt-to-Equity Comparison
For the Health Information Services subindustry, DXS International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DXS International Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DXS International's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where DXS International's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DXS International (AQSE:DXSP) has a Debt-to-Equity of 1.30 as of Apr. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on DXS International and its competitors. This is 348% above median its historical median of 0.29. Over the past decade, DXS International's Debt-to-Equity has ranged from 0.13 to 1.55. According to the industry distribution chart, DXS International ranks #448 out of 562 companies in the Healthcare Providers & Services industry, placing it in the top 79.7%.
Is DXS International's Debt-to-Equity too high?
DXS International's current Debt-to-Equity of 1.30 is 348% above median its 10-year median of 0.29. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 1.55. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. DXS International's value of 1.30 is 209.5% above this industry median. Based on the distribution chart, DXS International ranks #448 out of 562 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does DXS International's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #448 out of 562 companies for Debt-to-Equity. This places DXS International in the lower half of its industry. The industry median Debt-to-Equity is 0.42. DXS International's value of 1.30 is 209.5% above this benchmark. Historically, DXS International's own Debt-to-Equity has ranged from 0.13 to 1.55 over the past decade. While the company's 10-year median is 0.29 vs. the industry median of 0.42, DXS International has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DXS International's current Debt-to-Equity of 1.30 is 209.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current Debt-to-Equity is 1.30, which is 348% above median its own 10-year median of 0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Fairly Valued. The stock's GF Value™ is £0.02, compared to a current price of £0.02 — trading 5% above its estimated fair value. The current Debt-to-Equity is 1.30, which is 348% above median its 10-year median of 0.29 and 209.5% above the Healthcare Providers & Services industry median of 0.42. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Debt-to-Equity is 1.30 as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AQSE:DXSP has been successfully added to your 
